2025 Annual Report of Independent Director (Li Wei)
As an independent director of Zhongwei New Materials Co., Ltd. (hereinafter referred to as "the Company"), I, Li Wei, have fulfilled my duties in accordance with the Company Law, Securities Law, and other relevant laws and regulations, as well as the Company’s Articles of Association and the Independent Director Work System. During the 2025 fiscal year, I regularly monitored the Company’s financial and operational status, diligently performed my responsibilities, and actively upheld the independence and professionalism of the independent director role, safeguarding the overall interests of the Company and the legitimate rights of all shareholders, especially minority shareholders.
I have served as an independent director since November 10, 2019, completing a six-year term. In accordance with the regulations regarding the tenure of independent directors, I have applied to resign from my position as an independent director of the Company’s second board and from all related committee roles, and I will no longer hold any position in the Company after my resignation.
The following is a report on my performance during my tenure from January 1, 2025, to October 15, 2025:
1. Basic Information of the Independent Director
I, Li Wei, male, born in September 1981, hold Chinese nationality and do not have permanent residency abroad. I have a Ph.D. in Applied Economics from Hunan University. Since August 2010, I have served as an assistant professor, associate professor, and professor at the School of Economics and Trade, Hunan University. Since November 2023, I have been an independent director of Changsha Jinwei Integrated Circuit Co., Ltd. My tenure as an independent director of the Company from November 2019 to October 2025 meets the independence requirements stipulated in Article 6 of the Management Measures for Independent Directors of Listed Companies, and there are no circumstances affecting my independence.
2. Overview of Performance in 2025
(1) Attendance at Board and Shareholder Meetings
In 2025, the convening of the Company’s board and shareholder meetings complied with the relevant provisions of the Company Law and the Articles of Association. The financial assistance, issuance of H shares, annual related party transactions, and other significant matters were conducted in accordance with the relevant procedures, legally and effectively. During my tenure (from January 1, 2025, to October 15, 2025), my attendance at board and shareholder meetings was as follows: